GENE ONLINE|News &
May 2, 2013: U.S. Research Team Published the First Genetic Test Predicting Surgery Efficacy
On May 2, 2013, the U.S. research team published a seven-year research report in the American Journal of Human Genetics, announcing the first genetic test to predict benefits of gastric bypass surgery, also known as Roux-en-Y gastric bypass (RYGB). The test results can be used to determine the long-term success rate of RYGB with up to 70% of accuracy. Discovery of the correlation between certain genes and the effect of RYGB stands for a strong evidence of how genetic factors influence patients’ response to surgery, and also represents a breakthrough in genetic technology on improving clinical medicne.
Reference
https://www.cell.com/ajhg/issue?pii=S0002-9297(13)X0006-0
Image Source
https://commons.wikimedia.org/wiki/File:Blausen_0776_Roux-En-Y_01.png
Author
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
